Pathological TDP-43 co-condenses with G3BP1 in stress granules, altering G3BP1's material properties. G3BP1 may template TDP-43 amyloidogenesis, and hybrid aggregates escape autophagy clearance with intercellular transmission via exosomes. While TDP-43 remains the proven therapeutic target, G3BP1 dynamics may serve as a biomarker of stress granule dysfunction.
**Molecular Mechanism and Rationale**
The TAR DNA-binding protein 43 (TDP-43), encoded by the TARDBP gene, serves as a critical RNA-binding protein (RBP) that orchestrates complex post-transcriptional regulatory networks essential for neuronal homeostasis. Under physiological conditions, TDP-43 functions as a master regulator of cryptic exon silencing through its preferential binding to UG-rich and GU-rich sequences located within introns and 3' untranslated regions of target transcripts. The p
Verdict Summary
1/10
dimensions won
G3BP1-TDP-43 Cross-Seeding Drives Co-Agg
9/10
dimensions won
Cryptic Exon Silencing Restoration
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.42
0.75
Evidence
0.52
0.70
Novelty
0.72
0.65
Feasibility
0.40
0.60
Impact
0.60
0.72
Druggability
0.25
0.58
Safety
0.40
0.55
Competition
0.55
0.68
Data
0.58
0.75
Reproducible
0.50
0.62
Score Breakdown
Dimension
G3BP1-TDP-43 Cross-Seeding Dri
Cryptic Exon Silencing Restora
Mechanistic
0.420
0.750
Evidence
0.520
0.700
Novelty
0.720
0.650
Feasibility
0.400
0.600
Impact
0.600
0.720
Druggability
0.250
0.580
Safety
0.400
0.550
Competition
0.550
0.680
Data
0.580
0.750
Reproducible
0.500
0.620
Evidence
G3BP1-TDP-43 Cross-Seeding Drives Co-Aggregation That Prion-
No evidence citations yet
Cryptic Exon Silencing Restoration
No evidence citations yet
Debate Excerpts
G3BP1-TDP-43 Cross-Seeding Drives Co-Aggregation T
# Critical Evaluation of G3BP1 Neurodegeneration Hypotheses
I'm a rigorous scientific Skeptic. My job is to identify weaknesses, not to build confidence. What follows is a systematic critique of each...
Domain Expert
# Domain Expert Assessment: G3BP1 Neurodegeneration Hypotheses
## Executive Summary
Following integration of the Skeptic's mechanistic critiques with drug discovery feasibility analysis, **three hyp...